from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3010c/pfkA

LFCtreatmentdescriptionclass of inhibitor

-0.538

Amikacinug/mL Amikacintranslation

-0.161

Cap5-10ug/mL Capreomycintranslation

-0.015

Rox10-50 ug/mL Roxithromycintranslation

-0.067

SM2-5 ug/mL Streptomycintranslation

-0.856

Tet5-10 ug/mL Tetracyclinetranslation

-0.542

Rif0.2-5ug/mL Rifampicintranscription

-0.390

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.187

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.062

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.606

CPZ10-50 ug/mL Chlorpromazinerespiration

0.139

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.174

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.626

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.205

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.736

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.074

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.188

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.533

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.360

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.171

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.908

KCN5-20 ug/mL Potassium cyaniderespiration

-0.582

NaN30.2-2 mM Sodium aziderespiration

0.031

Nigericin50 uM Nigericinrespiration

0.927

TRC10-150 ug/mL Triclosanrespiration

1.428

TRZ10-25 ug/mL Thioridazinerespiration

-0.526

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.019

menadione6-10 ug/mL Menadionerespiration

-0.289

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.732

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.950

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.233

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.351

NRP_1Non-replicating persistence stage 1dosRassociated

-0.261

Amp0.2mg/mL AmpicillincellWall

-0.435

Cephalexin20-100 ug/mL CephalexincellWall

-0.511

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.505

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.191

EMB10-20 ug/mL EthambutolcellWall

-0.568

Eta12-40 ug/mL EthionamidecellWall

-0.408

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.553

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.651

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.716

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.236

BZA0.12 mg/mL BenzamidearomaticAmides

0.408

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.659

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.599

H2O24 mM hydrogen peroxideDNAdamaging

-0.206

Levo10 ug/mL LevofloxacinDNAdamaging

-0.472

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.065

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.193

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.201

UVUV-irradiationDNAdamaging

0.143

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.485

Antimycin12.5-50 ug/mL Antimycin A?

-0.647

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.511

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.427

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.052

PA8240.2-2 ug/mL PA-824?

1.381

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.155

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.560

Verapamil50 uM Verapamil?

-0.476

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.969

methoxatin10-20 ug/mL Methoxatin?